NCT05517707

Brief Summary

The purpose of this study is to optimize the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 10, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2023

Completed
Last Updated

September 14, 2023

Status Verified

September 1, 2023

Enrollment Period

10 months

First QC Date

August 19, 2022

Last Update Submit

September 13, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Percentage of accurate verifications of anatomical locations of the tip of the Gravitas feeding tube.

    Data collected during the study will be post processed to refine the Gravitas placement algorithm. The position of the feeding tube tip as processed by the Gravitas placement algorithm will be compared to institutional standard of care.

    5 months

  • Percentage of accurate removals/dislodgements identified by the Gravitas dislodgement algorithm.

    Data collected during the study will be post processed to refine the Gravitas placement algorithm. The removal/dislodgement of the feeding tube tip as processed by the Gravitas placement algorithm will be compared to actual removal/verification of dislodgement by institutional standard of care.

    5 months

  • Adverse events (a) related to placement and (b) throughout the duration of the presence of the feeding tube within the patient.

    The number and type of adverse events will be collected.

    5 months

Study Arms (1)

Nasogastric tube group

Neonates age 0-18 weeks post-partum at enrollment with gestational age \> 28 weeks will have the Gravitas Feeding Tube placed using standard technique. Tube placement will be verified by the institution standard of care. Study tubes are to remain in place up to 30 days.

Device: Nasogastric Tube

Interventions

Temperature and impedance data will be collected from sensors embedded within the feeding tube wall.

Nasogastric tube group

Eligibility Criteria

Age0 Weeks - 18 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates in NICU

You may qualify if:

  • Age at enrollment: 0 to 18 weeks post-partum. Can be up to 12 weeks preterm (gestational age ≥ 28 weeks).
  • Suitable to start enteral feeding
  • Anticipated to receive enteral feeding (either bolus or continuous feeds) for more than 6 hours and conclude the enteral nutrition while in the care of the NICU. If enteral nutrition has already been initiated, indicated for replacement of an orogastric/nasogastric feeding tube.

You may not qualify if:

  • Known major upper airway malformation (e.g. tracheoesophageal fistula)
  • Known major GI malformation (e.g. malrotation)
  • NPO status -neonate expected to remain NPO for the following 72 hours
  • Has a medical condition that drastically affects gastric acid-secretion (e.g. Zollinger-Ellison Syndrome, congenital achlorhydria, gastrointestinal perforation/leak/obstruction)
  • Has had removal of part of the stomach
  • Critically ill, facing imminent death
  • Neonate on ECMO
  • Deemed unsuitable for enrollment in study by the site principal investigator based on the patients' medical history
  • Ability to have a legally authorized representative provide informed consent
  • Both neonates on a ventilator (non-invasive or invasive ventilation) or not requiring a ventilator are eligible for this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lucile Packard Children's Hospital

Palo Alto, California, 94304, United States

Location

MeSH Terms

Interventions

Enteral Nutrition

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2022

First Posted

August 26, 2022

Study Start

November 10, 2022

Primary Completion

August 29, 2023

Study Completion

August 29, 2023

Last Updated

September 14, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations